Isotretinoin Sandoz

Isotretinoin, the active ingredient in Isotretinoin Sandoz, is a retinoid presented as an oral formulation for systemic use. It is indicated for the treatment of severe recalcitrant nodular acne and other forms of acne vulgaris in patients who have not responded to conventional therapies, and is often prescribed by dermatologists.

GNH USA supplies Isotretinoin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Isotretinoin is a retinoid used in the management of severe acne conditions.

Severe recalcitrant nodular acne: reduces lesion count and prevents new nodule formation. Severe cystic acne: diminishes deep inflammatory lesions and promotes skin healing. Acne vulgaris: improves overall acne severity and decreases oily skin production.

Isotretinoin may cause a range of adverse reactions.

Common Side Effects: - Dry skin and lips (cheilitis). - Nasal dryness and epistaxis. - Mild headache. - Elevated triglyceride levels. - Musculoskeletal discomfort. - Photosensitivity.

Serious or Rare Side Effects: - Teratogenicity (birth defects). - Severe depression or suicidal ideation. - Inflammatory bowel disease. - Significant liver enzyme elevation. - Pseudotumor cerebri. - Hypercalcemia.

Before initiating therapy, several safety measures are required.

Pregnancy testing: confirm negative result and use effective contraception throughout treatment and for one month after discontinuation. Liver function monitoring: assess baseline and periodic hepatic enzymes. Lipid profile monitoring: check triglycerides and cholesterol levels regularly. Avoid vitamin A supplements: excess retinoids increase toxicity risk. Do not combine with tetracycline antibiotics: risk of intracranial hypertension. Store at ambient temperature: keep in the original pack, protect from moisture and light.

Isotretinoin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Tetracycline antibiotics: may precipitate pseudotumor cerebri. - Vitamin A supplements: increase risk of retinoid toxicity. - Systemic corticosteroids: heighten intracranial hypertension risk.

Moderate Interactions (Monitor Closely): - Other oral retinoids: additive teratogenic potential. - Hepatotoxic drugs (e.g., azole antifungals): may exacerbate liver enzyme elevations. - Lipid‑lowering agents (e.g., fibrates): monitor triglyceride levels closely.